Opening Remarks: 2nd Conjoint RIKEN–ISM Targeting Microbiota 2026
Masayuki Amagai, Center Director, RIKEN Center for Integrative Medical Sciences (IMS), Japan
Can IgA Reprogram the Human Gut Microbiota in Inflammatory Bowel Disease?
Reiko Shinkura, The University of Tokyo, Japan
Gut Microbes, Tryptophan Metabolism, and Pulmonary Hypertension: A Targetable Gut–Lung Axis
Yoshikazu Nakaoka, National Cerebral and Cardiovascular Center Research Institute, Japan
When Synapses Shape the Microbiome: Decoding the Gut–Brain Axis in Autism
Elisa Hill-Yardin, RMIT University, Australia
The Microbiota Sends the Signal. Do Mitochondria Decide the Response?
Marvin Edeas, Université de Paris, France
From Quorum-Sensing-Driven Pathogenesis to Microbiome: Targeted Therapies in Atopic Dermatitis
Yumi Matsuoka, The University of Osaka, Japan
Microbial Metabolites as Drivers of Gastric Mucosal Defense
Naoko Satoh-Takayama, RIKEN Center for Integrative Medical Sciences (IMS), Japan
Microbiota-Metabolite Control of Cardiac Injury and Repair
Patrick C.H. Hsieh, Institute of Biomedical Sciences, Academia Sinica, Taiwan
The Microbiota–Muscle Axis in Aging: How Trimethylamine N-Oxide (TMAO) Remodels Mitochondria and Promotes Sarcopenia
Ippei Shimizu, National Cerebral and Cardiovascular Center Research Institute, Japan
Single-Cell Visualization and Australia’s Human Microbiome Biobank: New Tools for Strain-Level Microbiome Science
Gene Tyson, Queensland University of Technology, Australia
From Strain Diversity to Mobile Element Dynamics in Human Microbiomes with Single-Cell Genomics
Masahito Hosokawa, Waseda University, Japan
Single-Cell Ramanomics Platform Enables Rapid Probiotic Quality Assessment and Strain Traceability
Jian Xu, Qingdao Institute of BioEnergy and Bioprocess Technology - CAS, China
Living Probiotics, Microbial Metabolites, and Mitochondrial Resilience: A Pathway to Healthy Aging
Dongryeol Ryu, Gwangju Institute of Science and Technology (GIST), Korea
Engineering Mitochondrial Stress Tolerance through Mitochondria-Targeted Nanocapsules: Perspectives on the Microbiota–Mitochondria Axis
Yuma Yamada, Hokkaido University, Japan
Carotenoid Metabolism Regulates the Microbiota–Mitochondria Axis: From Diet to Single-Cell Heterogeneity
Dingbo Lin, Oklahoma State University, USA
Strain and Function-Resolved Metagenomics to Identify Microbial Drivers of Chronic Disease
Wataru Suda, RIKEN Center for Integrative Medical Sciences (IMS), Japan
Precision Microbiome Therapeutics to Enhance Cancer Immunotherapy
Sin-Hyeog Im, Pohang University of Science and Technology (POSTECH), Korea
Development of Smart Biodelivery Systems for Personalized Disease Treatment Based on the Gut Microbiome
GwangPyo Ko, Seoul National University, Korea
Resolving Microbial Drivers of Colorectal Cancer: From Population Signatures to Strain-level Resolution and Mutational Footprints
Takuji Yamada, Institute of Science Tokyo, Japan
Concluding Remarks: 2nd Conjoint RIKEN–ISM Targeting Microbiota 2026
Hiroshi Ohno, RIKEN Center for Integrative Medical Sciences (IMS), Japan
